Harvard Bioscience (HBIO) Long-Term Deferred Tax (2010 - 2019)

Harvard Bioscience (HBIO) has 10 years of Long-Term Deferred Tax data on file, last reported at $210000.0 in Q2 2019.

• On a quarterly basis, Long-Term Deferred Tax rose 18.64% year-over-year to $210000.0 in Q2 2019; TTM through Jun 2019 was $210000.0, a 18.64% increase from a year earlier, with the FY2017 full-year figure at $182000.0, up 103.46% from the prior year.
• Long-Term Deferred Tax for Q2 2019 stood at $210000.0, up from $208000.0 in the prior quarter.
• Over the last five years, Long-Term Deferred Tax for HBIO reached as high as $11.0 million in Q3 2015 and fell as low as -$5.3 million in Q4 2016.
• Historically, Long-Term Deferred Tax has averaged $2.2 million across 5 years, with a median of $995000.0 in 2015.
• Across the five-year window, Long-Term Deferred Tax plunged 628.64% in 2016 and jumped 103.46% in 2017, its largest moves.
• Year by year, Long-Term Deferred Tax stood at $995000.0 in 2015, then plunged by 628.64% to -$5.3 million in 2016, then soared by 103.46% to $182000.0 in 2017, then decreased by 1.65% to $179000.0 in 2018, then rose by 17.32% to $210000.0 in 2019.
• Per Business Quant data, the three most recent Long-Term Deferred Tax figures were $210000.0 in Q2 2019, $208000.0 in Q1 2019, and $179000.0 in Q3 2018.